Cases & Deals

Stentys completes €7.5 private placement of Common Stock

Clients Stentys

Jones Day advised Stentys, a medical technology company commercializing the world's first and only self-apposing stent to treat Acute Myocardial Infarction listed on the regulated market of NYSE Euronext in Paris, in connection with its issuance of €7.5 million (US$9.8 million) of Common Stock in a private placement.

In addition, Jones Day also advised Société Générale Corporate & Investment Banking and Kempen & Co, who acted as joint lead managers and joint bookrunners.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.